Video Experimental Relacionado

Updated: May 4, 2026

Transient Expression in Red Beet of a Biopharmaceutical Candidate Vaccine for Type-1 Diabetes

Transient Expression in Red Beet of a Biopharmaceutical Candidate Vaccine for Type-1 Diabetes

Published on: March 19, 2019

Validar el Registro de Vacunas de Georgia para la Temporada COVID-19 2023-2024: Verdaderos GRITS

Allison D Roebling¹, Nathaniel Elijah Barrera-Nitz¹, Melissa Tobin-D'Angelo¹

¹Allison D. Roebling, Nathaniel Elijah Barrera-Nitz, Kyle P. Openo, and Lucy S. Witt are with the Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, and the Georgia Emerging Infections Program, Atlanta. Melissa Tobin-D'Angelo is with the Georgia Department of Public Health, Atlanta, GA.

American journal of public health

|February 11, 2026

Resumen

Se trata de Georgia Georgia Georgia Georgia.

Área de la Ciencia:

Salud Pública La salud pública.
Epidemiología La epidemiología.
Sistemas de inmunización Sistemas de inmunización

Sus antecedentes:

La presentación de informes precisos sobre la vacuna COVID-19 es crucial para la vigilancia de la salud pública.
El Registro de Transacciones y Servicios de Inmunización de Georgia (GRITS) es el sistema de información de inmunización del estado.
La evaluación de la integridad de los GRITS es vital para comprender la cobertura de vacunas.

Objetivo del estudio:

Evaluar la integridad de los informes de vacunas contra la COVID-19 por parte de los proveedores de atención médica a GRITS.
Para evaluar la precisión de los datos para pacientes hospitalizados con COVID-19 en el área metropolitana de Atlanta entre el 1 de octubre de 2023 y el 31 de diciembre de 2023.

Principales métodos:

La vigilancia activa, poblacional y de laboratorio identificó hospitalizaciones por COVID-19 en 8 condados metropolitanos de Atlanta.
Un subconjunto de pacientes fue muestreado aleatoriamente para una revisión detallada de la tabla.
El seguimiento telefónico con pacientes, representantes, farmacias y médicos verificó el estado de vacunación e identificó dosis no registradas.

Principales resultados:

2165 hospitalizaciones por COVID-19 ocurrieron durante el período de estudio.
El seguimiento identificó solo 1 dosis de vacuna COVID-19 no registrada en el registro.
Los extensos esfuerzos de seguimiento dieron como resultado datos de vacunación adicionales mínimos.

Conclusiones:

El registro GRITS demuestra una alta integridad para el estado de vacunación contra COVID-19 entre los pacientes hospitalizados en el metro de Atlanta.
El registro es una fuente confiable de datos de inmunización en esta población.
Es poco probable que un seguimiento más intensivo mejore significativamente la integridad de los datos.

Más Videos Relacionados

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Author Spotlight: Rabies-Specific Antibody Isotypes Detection in Sera or Cerebral Spinal Fluid Using an IFA Test

Author Spotlight: Rabies-Specific Antibody Isotypes Detection in Sera or Cerebral Spinal Fluid Using an IFA Test

Published on: January 19, 2024

Videos de Conceptos Relacionados

Vaccinations

Vaccinations

Bioequivalence studies: Biowaivers

Bioequivalence studies: Biowaivers

In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...

Vaccine Production

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...

Influenza

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...